Twice‐a‐day PPI, tetracycline, metronidazole quadruple therapy with Pylera® or L a ctobacillus reuteri for treatment naïve or for retreatment of Helicobacter pylori . Two randomized pilot studies-Reference-Cited by-同舟云学术

Twice‐a‐day PPI, tetracycline, metronidazole quadruple therapy with Pylera® or L a ctobacillus reuteri for treatment naïve or for retreatment of Helicobacter pylori . Two randomized pilot studies

Published:2019-09-09 Issue:6 Volume:24 Page:
ISSN:1083-4389
Container-title:Helicobacter
language:en
Short-container-title:Helicobacter

Author:

Dore Maria Pina¹²^ORCID,Bibbò Stefano¹,Loria Mariafrancesca¹,Salis Roberta¹,Manca Alessandra¹,Pes Giovanni Mario¹^ORCID,Graham David Yates²³^ORCID

Affiliation:

1. Dipartimento di Scienze Mediche, Chirurgiche e Sperimentali University of Sassari Italy

2. Baylor College of Medicine Houston Texas

3. Department of Medicine Michael E. DeBakey VAMC Houston Texas

Publisher

Wiley

Subject

Infectious Diseases,Gastroenterology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hel.12659

Reference31 articles.

1. Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication

2. Use of high efficacy, lower dose triple therapy to reduce side effects of eradicating Helicobacter pylori;Borody TJ;Am J Gastroenterol,1994

3. Bismuth triple therapy: still a very important drug regimen for curing Helicobacter pylori infection;Boer WA;Eur J Gastroenterol Hepatol,1999

4. How to Effectively Use Bismuth Quadruple Therapy

5. Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of probiotic as adjuvant in treating various infections: a systematic review and meta-analysis;BMC Infectious Diseases;2024-05-21

2. Lactobacillus reuteri in digestive system diseases: focus on clinical trials and mechanisms;Frontiers in Cellular and Infection Microbiology;2023-08-18

3. Belgian consensus for Helicobacter pylori management 2023;Acta Gastro Enterologica Belgica;2023-03

4. Integrative ATAC-seq and RNA-seq analyses of IPEC-J2 cells reveals porcine transcription and chromatin accessibility changes associated with Escherichia coli F18ac inhibited by Lactobacillus reuteri;Frontiers in Microbiology;2023-02-16

5. 2022 Chinese national clinical practice guideline on Helicobacter pylori eradication treatment;Chinese Medical Journal;2022-12-20